Actinium Pharmaceuticals (ATNM) Stock: Buy, Sell, or Hold?
$1.59
+0.00 (+0.00%)
▲
5d:
+22.31%
30d:
+63.14%
90d:
+52.88%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (21%)
Quality Score
43/100
Position
EXTENDED
30-Day Fair Range
$1.10 – $1.48
Position: EXTENDED
Forward P/E & Valuation
-3.0x
Next 12M consensus est.
Wall Street Target
$4.00
+151.6% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$1.28 / $1.67
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
📊 MIXED SIGNALS: ATNM shows conflicting indicators. Wait for confirmation before entering.
Get Alerted When ATNM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: ATNM is currently trading at $1.59, which is considered extended relative to its 30-day fair value range of $1.10 to $1.48.
Technical Outlook: Technically, ATNM is in a strong uptrend. Immediate support is located at $1.28, while resistance sits at $1.67.
Market Sentiment: ATNM scores 32/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $4.00 (+151.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ATNM is in a strong uptrend. Immediate support is located at $1.28, while resistance sits at $1.67.
Market Sentiment: ATNM scores 32/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $4.00 (+151.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.10 -
$1.48
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
21.1%
Trading Range & Key Levels
30-Day Trading Range
$1.10 -
$1.48
Current vs Trading Range
EXTENDED
Support Level
$1.28
Resistance Level
$1.67
Current Trend
Strong Uptrend
Technical data as of
Nov 12, 2026
Quantitative Signal Breakdown
- BEARISH: Price extended above range (+7.4% above its trading range)
- BEARISH: Weak technical setup (32/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 151.6% below Wall St target ($4.00)
- WARNING: Composite score 42/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-3.03
Wall Street Target
$4.00
(+151.6%)
Revenue Growth (YoY)
-100.0%
Profit Margin
32.2%
Share ATNM Analysis
Share this live ATNM analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (ATNM)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 12, 2026
Daily AI digest
AI Retail Discussion Summary:
Actinium Pharmaceuticals announced a KOL webinar on December 1, 2026, to discuss the potential of ATNM-400, its first-in-class HER3-targeted alpha radiotherapy for metastatic castration-resistant prostate cancer. Michael J. Morris, MD, of Memorial Sloan Kettering Cancer Center, will lead the discussion.
Key Retail Themes:
ATNM-400's potential in the mCRPC market
Upcoming KOL webinar
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 7:53 PM ET
Data refreshes hourly during market hours. Next update: 8:53 PM
Data refreshes hourly during market hours. Next update: 8:53 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ATNM showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
REGN
Regeneron Pharmaceutical… |
BUY
28 analysts |
$978 | 32 SELL |
|
PRAX
Praxis Precision Medicin… |
STRONG BUY
21 analysts |
$650 | 32 SELL |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
22 analysts |
$296 | 24 SELL |
|
DYN
Dyne Therapeutics Inc |
STRONG BUY
17 analysts |
$34 | 49 HOLD |
|
ACAD
ACADIA Pharmaceuticals I… |
STRONG BUY
20 analysts |
$31 | 48 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive ATNM Research Pages
